< Terug naar vorige pagina

Publicatie

Overcoming cetuximab resistance in HNSCC

Tijdschriftbijdrage - Tijdschriftartikel

Ondertitel:the role of AURKB and DUSP proteins
Unraveling the underlying mechanisms of cetuximab resistance in head and neck squamous cell carcinoma (HNSCC) is of major importance as many tumors remain non-responsive or become resistant. Our microarray results suggest that resistant cells still exhibit RASMAPK pathway signaling contributing to drug resistance, as witnessed by low expression of DUSP5 and DUSP6, negative regulators of ERK1/2, and increased expression of AURKB, a key regulator of mitosis. Therefore, interrupting the RASMAPK pathway by an ERK1/2 inhibitor (apigenin) or an AURKB inhibitor (barasertib) might be a new strategy for overcoming cetuximab resistance in HNSCC.
Tijdschrift: Cancer letters
ISSN: 0304-3835
Volume: 354
Pagina's: 365 - 377
Jaar van publicatie:2014
BOF-keylabel:ja
Authors from:Higher Education